tiprankstipranks
Trending News
More News >
Tonix Pharma (TNXP)
NASDAQ:TNXP
US Market

Tonix Pharma (TNXP) Income Statement

Compare
4,481 Followers

Tonix Pharma Income Statement

Last quarter (Q4 2024), Tonix Pharma's total revenue was $2.58M, a decrease of -31.68% from the same quarter last year. In Q4, Tonix Pharma's net income was $-22.11M. See Tonix Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.09M$ 7.77M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 2.33M$ 3.03M$ -112.09M$ -92.31M$ -50.51M
Operating Expenses
$ 139.03M$ 121.41M$ 112.09M$ 92.31M$ 50.51M
Depreciation and Amortization
$ 3.42M$ 4.29M$ 1.25M$ 50.00K$ 27.00K
EBITDA
$ -71.73M$ -114.09M$ -110.84M$ -92.26M$ -50.48M
Operating Income
$ -136.70M$ -118.38M$ -112.09M$ -92.31M$ -50.51M
Other Income/Expenses
$ 6.67M$ 1.72M$ 1.87M$ 25.00K$ 48.00K
Pretax Income
$ -130.04M$ -116.66M$ -110.22M$ -92.29M$ -50.46M
Net Income
$ -130.04M$ -116.66M$ -116.88M$ -92.29M$ -52.17M
Per Share Metrics
Basic EPS
$ -176.60$ -219.09$ -640.26$ -1.62K$ -3.53K
Diluted EPS
$ -176.60$ -219.09$ -640.26$ -1.62K$ -3.53K
Weighted Average Shares Outstanding
736.34K 532.48K 182.54K 56.94K 14.78K
Weighted Average Shares Outstanding (Diluted)
736.34K 532.48K 182.54K 56.94K 14.78K
Currency in USD

Tonix Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis